Gilead Sciences (NASDAQ: GILD) files 13F reporting $1.79B holdings

Rhea-AI Filing Summary

Gilead Sciences, Inc. filed a Form 13F reporting its institutional holdings. The filing is a 13F Holdings Report signed by Andrew D. Dickinson, Executive Vice President and Chief Financial Officer, dated 11-13-2025.

The report lists 9 information-table entries with a total value of $1,791,467,184 and names one other included manager, Gilead Therapeutics A1 Unlimited Co (Form 13F File No. 028-25083).

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE

OMB APPROVAL

OMB Number:			3235-0006
Estimated average burden
hours per response:			23.8

Report for the Calendar Year or Quarter Ended: 09-30-2025

Check here if Amendment		Amendment Number:
This Amendment (Check only one.):		is a restatement.
		adds new holdings entries.

Institutional Investment Manager Filing this Report:
Name:	GILEAD SCIENCES, INC.
Address:	333 LAKESIDE DR
	FOSTER CITY, CA 94404
Form 13F File Number:	028-25078
CRD Number (if applicable):
SEC File Number (if applicable):

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:
Name:		Andrew D. Dickinson
Title:		Executive Vice President and Chief Financial Officer
Phone:		650-574-3000
Signature, Place, and Date of Signing:
/s/ Andrew D. Dickinson			FOSTER CITY, CA	11-13-2025
[Signature]			[City, State]	[Date]

Report Type (Check only one.):
X	13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
	13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
	13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)

Form 13F Summary Page
	Report Summary:
	Number of Other Included Managers:		1
	Form 13F Information Table Entry Total:		9
	Form 13F Information Table Value Total:		1,791,467,184
			(round to nearest dollar)

List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
[If there are no entries in this list, state "NONE" and omit the column headings and list entries.]
	No.	Name	Form 13F File No.	CRD No. (if applicable)	SEC File No. (if applicable)	CIK
	1	Gilead Therapeutics A1 Unlimited Co	028-25083			0002055207

FAQ

What does GILD's Form 13F filing show?

The filing shows Gilead filed a 13F Holdings Report listing 9 reported positions. It discloses an aggregate reported value of $1,791,467,184 and one other included manager, Gilead Therapeutics A1 Unlimited Co.

Who signed Gilead's Form 13F and when was it signed?

Andrew D. Dickinson, Executive Vice President and Chief Financial Officer, signed the report. The signature block shows the filing was signed in Foster City, CA on 11-13-2025.

How many holdings entries are reported for Gilead (GILD)?

The report summary lists an Information Table Entry Total of 9 holdings entries. This count appears on the Form 13F summary page as provided in the filing excerpt.

What is the total value reported on Gilead's 13F?

The Form 13F information table value total is reported as $1,791,467,184. That figure is shown on the summary page rounded to the nearest dollar in the filing excerpt.

Does the filing list other included managers for Gilead's 13F?

Yes; the filing lists one other included manager: Gilead Therapeutics A1 Unlimited Co with Form 13F File No. 028-25083. The report includes this manager in its disclosure table.